首页 | 本学科首页   官方微博 | 高级检索  
   检索      

纳米细菌与冠心病
引用本文:尹倪,陈胜喜.纳米细菌与冠心病[J].医学与哲学,2004,25(8):44-45.
作者姓名:尹倪  陈胜喜
作者单位:中南大学湘雅医院心胸外科,湖南,长沙,410078
摘    要:最近新发现的纳米细菌是目前已知的最小的细菌,其直径为几十至几百纳米.与其它细菌不同,它们是一种生长繁殖缓慢,能通过普通滤菌器(0.2um),吴有生物矿化作用和一定抗辐射能力,革兰氏染色阴性的球形细菌.它们最特殊的生物学特性是可以在生理状态的钙、磷浓度下分泌主要由羟磷石灰碳酸盐构成的保护性外壳.因此,它们被认为与机体内病理性钙化密切相关.近年来研究发现,它们可能是冠心病的一种感染性致病源.抗纳米细菌治疗的临床实验显示在冠心病患者中具有一定疗效.

关 键 词:纳米细菌  冠心病  病理性钙化  微生物  生物矿化作用

Nanobacteria and Coronary Heart Disease
YIN Ni,CHEN Sheng-xi.Nanobacteria and Coronary Heart Disease[J].Medicine & Philosophy:Humanistic & Social Medicine Edition,2004,25(8):44-45.
Authors:YIN Ni  CHEN Sheng-xi
Institution:YIN Ni,CHEN Sheng-xi.Department of Thoracic and Cardiovascular Surgery,Xiang Ya Hospital,Central South University,Changsha 410078,China
Abstract:Nanobacteria discovered recently are smallest bacteria as we know now, whose diameter are tens or hundreds nanometer. They are a kind of mineral-forming, sterile-filterable, slow-growing, radio-resistant and Gram-negative bacteria. Their most remarkable characteristic is forming a hard protective shelter made of carbonate apatite crystals at physiologic phosphate and calcium concentrations. They are thought to play an important part in the process of pathologic calcification. Resent researches demonstrate that nanobacteria may be a novel infectious agent of coronary heart disease. Anti-nanobacteria therapy has shown potential positive effect in some clinical experiments.
Keywords:nanobacteria  coronary heart disease  pathologic calcification  microorganism  biological mineralization
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号